Cardiac ARrest : Brain OXymetry Depending on HYpothermia Depth (CARBOXHYD)

March 21, 2023 updated by: Centre Hospitalier Universitaire de Nice

Evaluation de l'oxymétrie cérébrale à Deux Niveaux d'Hypothermie thérapeutique après arrêt Cardiaque Extra-hospitalier

Cardiac arrest is a major public health problem, with 700 000 cases per year , and a survival ranging from 4 to 33%. The post- anoxic encephalopathy remains the most serious complication with only a third of survivors . It is due to a series of phenomena involving microcirculation disorders . Cerebral oximetry is a new technique to evaluate the microcirculatory status . To this day it is used in cardiovascular surgery at risk of cerebral hypoperfusion where desaturation of cerebral oximetry is synonymous with ischemia and microcirculatory disorders. Therapeutic hypothermia is the only treatment improves the outcome of patients after extra- hospital cardiac arrest resuscitation . Its mechanisms of action seem to change all the phenomena responsible for microcirculatory reperfusion disorders . Currently it is recommended to practice hypothermia between 32 and 34 ° C. However, a recent study suggests a superiority of hypothermia at 32 ° C rather than 34 ° C.

The hypothesis of this study is that cerebral oximetry value will be different in patients subjected to two different levels of therapeutic hypothermia in the aftermath of an extra- hospital cardiac arrest. These data allow a better understanding of the mechanisms underlying the benefit of this technique.

Study Overview

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Fréjus, France, 83608
        • CH de Fréjus-Saint Raphael
      • Nice, France, 06000
        • CHU de Nice - Hôpital Saint Roch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient presented with an extra-hospital cardiac arrest resuscitation and to benefit from therapeutic hypothermia using a servo system to its temperature (CoolGard 3000 ® system)
  • Age> 18 years and <80 years

Exclusion Criteria:

  • Major Patient protected by law
  • Private person administrative or judicial freedom
  • Neurological or traumatic cause of cardiac arrest
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 34°C
therapeutic hypothermia at 34 ° C
Experimental: 32°C
therapeutic hypothermia at 32 ° C

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mesure of cerebral oximetry
Time Frame: 8 times during the first 48 hours of hospitalization
During the first 48 hours of hospitalization, we will collect the cerebral oximetry values in the two cerebral hemispheres.
8 times during the first 48 hours of hospitalization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The cerebral oximetry values (average of the two hemispheres) will be compared between patients with good and poor neurological outcome.
Time Frame: 8 times during the first 48 hours of hospitalization
The cerebral oximetry values (average of the two hemispheres) will be compared between patients with good and poor neurological outcome.
8 times during the first 48 hours of hospitalization
For each level of therapeutic hypothermia the cerebral oximetry values will be compared between patients with good and poor becoming
Time Frame: baseline, when target temperature is reached, 6 hours, 12 hours, 18 hours, 24 hours, when 37°C is reached
For each level of therapeutic hypothermia (32 or 34 ° C), the cerebral oximetry values (average of the two hemispheres) will be compared between patients with good and poor becoming according to the CPC score (CPC = 1 become good score - 2 and bad become CPC = 3-5).
baseline, when target temperature is reached, 6 hours, 12 hours, 18 hours, 24 hours, when 37°C is reached
Outcome of patients
Time Frame: 6 months after hospitalization
The outcome of patients (score 1-2 vs. CPC. 3-5 CPC) will be compared with the level of hypothermia (32 or 34 ° C)
6 months after hospitalization
Mesure of lactate
Time Frame: 4 times during the first 48 hours of hospitalization
Lactate will be compared between patients with good (CPC 1-2) and poor (CPC 3-5) become throughout the study population
4 times during the first 48 hours of hospitalization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jean-Christophe ORBAN, MD, Centre Hospitalier Universitaire de Nice

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2014

Primary Completion (Actual)

March 9, 2017

Study Completion (Actual)

March 9, 2017

Study Registration Dates

First Submitted

November 20, 2013

First Submitted That Met QC Criteria

January 31, 2014

First Posted (Estimate)

February 3, 2014

Study Record Updates

Last Update Posted (Actual)

March 22, 2023

Last Update Submitted That Met QC Criteria

March 21, 2023

Last Verified

August 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 13-AOI-02
  • 2013-A01192-43 (Other Identifier: ANSM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on therapeutic hypothermia at 34 ° C

Subscribe